CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 17 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,025,000 | -51.4% | 559,900 | 0.0% | 0.31% | -58.2% |
| Q2 2017 | $2,111,000 | +2.5% | 559,900 | 0.0% | 0.75% | +0.5% |
| Q1 2017 | $2,060,000 | +8.2% | 559,900 | +55.6% | 0.74% | -26.6% |
| Q4 2016 | $1,904,000 | -11.8% | 359,900 | 0.0% | 1.02% | +13.4% |
| Q3 2016 | $2,159,000 | – | 359,900 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 21,000 | $28,000 | 0.00% |
| AJ WEALTH STRATEGIES, LLC | 12,677 | $17,000 | 0.00% |
| Virtu Financial LLC | 39,613 | $53,000 | 0.00% |
| BREWIN DOLPHIN LTD | 5,586 | $7,541 | 0.00% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 23 | $0 | 0.00% |
| UBS Group AG | 2,956 | $4,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,240 | $17,000 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $18,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $29,000 | 0.00% |